Open Access
Open access
BMC Genomics, volume 19, issue 1, publication number 762

New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe

Publication typeJournal Article
Publication date2018-10-22
Journal: BMC Genomics
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.4
ISSN14712164
Genetics
Biotechnology
Abstract
Ural genetic family is a part of the Euro-American lineage of Mycobacterium tuberculosis and is endemic in Northern Eurasia (former Soviet Union [FSU]). These strains were long described as drug susceptible and of low virulence, but recent studies reported an increasing circulation of the multidrug-resistant (MDR) and extensively drug-resistant (XDR) Ural strains. Here, we analyzed all publicly available whole genome sequence data of Ural genotype isolates, in order to elucidate their phylogenomic diversity with a special focus on MDR and potentially epidemic clones. A total of 149 M. tuberculosis genomes of Ural isolates from FSU countries were mined from the GMTV database and TB-ARC project. We identified 6002 variable amino acid positions that were assessed for functional significance and used to build ML, NJ trees and for Bayesian TMRCA estimation. Three robust monophyletic clades were identified: Clade A (31 isolates from Russia, Belarus, Moldova), Clade B (52 isolates from Russia), and Clade C (37 isolates from Moldova, 2 from Belarus). Clade C was significantly associated with XDR or pre-XDR status compared to the pooled Clades A and B (33/39 versus 5/83, P < 0.0001). Time of origin was estimated for Clade A at 77.7–137 years ago and for Clade B at 56.3–99.2 years ago compared to the significantly more recent origin for Clade C. in silico spoligotyping identified signatures specific of the Clade A (spoligotype SIT35), and Clades B and C (both SIT262). A genetically compact and evolutionarily young Ural Clade C, likely originated after collapse of the Soviet Union, and reached epidemic proportions in Moldova in the last 20 years. This epidemic pre-XDR clone (mostly rifampin, isoniazid and kanamycin resistant) is characterized by a specific combination of mutations: KatG Ser315Thr, fabG1 -15C > T, RpoB Ser450Leu, RpsL Lys88Arg, eis -12G > A and EmbB Ser297Ala/T > G. Its further dissemination may occur towards both Russia and European Union and should be taken into consideration by health authorities. The identified spoligotyping signatures can serve for rapid preliminary detection and surveillance of the more hazardous pre-XDR associated strains of the Ural family, both in populations from countries of their endemic circulation and migrant communities.

Citations by journals

1
2
3
4
5
Infection, Genetics and Evolution
Infection, Genetics and Evolution, 5, 18.52%
Infection, Genetics and Evolution
5 publications, 18.52%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2, 7.41%
International Journal of Antimicrobial Agents
2 publications, 7.41%
Acta Biomedica Scientifica (East Siberian Biomedical Journal)
Acta Biomedica Scientifica (East Siberian Biomedical Journal), 2, 7.41%
Acta Biomedica Scientifica (East Siberian Biomedical Journal)
2 publications, 7.41%
Microbial genomics
Microbial genomics, 1, 3.7%
Microbial genomics
1 publication, 3.7%
Antibiotics
Antibiotics, 1, 3.7%
Antibiotics
1 publication, 3.7%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 1, 3.7%
Frontiers in Cellular and Infection Microbiology
1 publication, 3.7%
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine, 1, 3.7%
Bulletin of Experimental Biology and Medicine
1 publication, 3.7%
PLoS Medicine
PLoS Medicine, 1, 3.7%
PLoS Medicine
1 publication, 3.7%
Tuberculosis
Tuberculosis, 1, 3.7%
Tuberculosis
1 publication, 3.7%
Data in Brief
Data in Brief, 1, 3.7%
Data in Brief
1 publication, 3.7%
New Microbes and New Infections
New Microbes and New Infections, 1, 3.7%
New Microbes and New Infections
1 publication, 3.7%
BMC Genomics
BMC Genomics, 1, 3.7%
BMC Genomics
1 publication, 3.7%
Transboundary and Emerging Diseases
Transboundary and Emerging Diseases, 1, 3.7%
Transboundary and Emerging Diseases
1 publication, 3.7%
Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular Therapy and Prevention (Russian Federation), 1, 3.7%
Cardiovascular Therapy and Prevention (Russian Federation)
1 publication, 3.7%
BMC Infectious Diseases
BMC Infectious Diseases, 1, 3.7%
BMC Infectious Diseases
1 publication, 3.7%
Tuberculosis and Lung Diseases
Tuberculosis and Lung Diseases, 1, 3.7%
Tuberculosis and Lung Diseases
1 publication, 3.7%
Vestnik KazNMU
Vestnik KazNMU, 1, 3.7%
Vestnik KazNMU
1 publication, 3.7%
Journal of microbiology epidemiology immunobiology
Journal of microbiology epidemiology immunobiology, 1, 3.7%
Journal of microbiology epidemiology immunobiology
1 publication, 3.7%
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika), 1, 3.7%
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
1 publication, 3.7%
1
2
3
4
5

Citations by publishers

2
4
6
8
10
Elsevier
Elsevier, 10, 37.04%
Elsevier
10 publications, 37.04%
Springer Nature
Springer Nature, 3, 11.11%
Springer Nature
3 publications, 11.11%
Scientific Centre for Family Health and Human Reproduction Problems
Scientific Centre for Family Health and Human Reproduction Problems, 2, 7.41%
Scientific Centre for Family Health and Human Reproduction Problems
2 publications, 7.41%
Microbiology Society
Microbiology Society, 1, 3.7%
Microbiology Society
1 publication, 3.7%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 1, 3.7%
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 3.7%
Frontiers Media S.A.
Frontiers Media S.A., 1, 3.7%
Frontiers Media S.A.
1 publication, 3.7%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 3.7%
Public Library of Science (PLoS)
1 publication, 3.7%
Wiley
Wiley, 1, 3.7%
Wiley
1 publication, 3.7%
Russian Society of Cardiology
Russian Society of Cardiology, 1, 3.7%
Russian Society of Cardiology
1 publication, 3.7%
Russian Phthisiologists’ Society
Russian Phthisiologists’ Society, 1, 3.7%
Russian Phthisiologists’ Society
1 publication, 3.7%
Asfendiyarov Kazakh National Medical University
Asfendiyarov Kazakh National Medical University, 1, 3.7%
Asfendiyarov Kazakh National Medical University
1 publication, 3.7%
Central Research Institute for Epidemiology
Central Research Institute for Epidemiology, 1, 3.7%
Central Research Institute for Epidemiology
1 publication, 3.7%
National Association of the Specialists in Control of Health Care-Associated Infections
National Association of the Specialists in Control of Health Care-Associated Infections, 1, 3.7%
National Association of the Specialists in Control of Health Care-Associated Infections
1 publication, 3.7%
2
4
6
8
10
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Sinkov V. et al. New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe // BMC Genomics. 2018. Vol. 19. No. 1. 762
GOST all authors (up to 50) Copy
Sinkov V., Ogarkov O., Mokrousov I. V., Bukin Y., Zhdanova S., Heysell S. K. New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe // BMC Genomics. 2018. Vol. 19. No. 1. 762
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1186/s12864-018-5162-3
UR - https://doi.org/10.1186%2Fs12864-018-5162-3
TI - New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe
T2 - BMC Genomics
AU - Sinkov, Viacheslav
AU - Ogarkov, Oleg
AU - Mokrousov, I. V.
AU - Bukin, Yuri
AU - Zhdanova, Svetlana
AU - Heysell, Scott K.
PY - 2018
DA - 2018/10/22 00:00:00
PB - Springer Nature
IS - 1
VL - 19
PMID - 30348088
SN - 1471-2164
ER -
BibTex
Cite this
BibTex Copy
@article{2018_Sinkov,
author = {Viacheslav Sinkov and Oleg Ogarkov and I. V. Mokrousov and Yuri Bukin and Svetlana Zhdanova and Scott K. Heysell},
title = {New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe},
journal = {BMC Genomics},
year = {2018},
volume = {19},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1186%2Fs12864-018-5162-3},
number = {1},
doi = {10.1186/s12864-018-5162-3}
}
Found error?